跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
王 淵宏
副教授
,
臨床醫學研究所
合聘副教授
,
國際醫學研究碩士學位學程
合聘副教授
,
國際醫學研究博士學位學程
醫學研究員
,
衛生福利部雙和醫院
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0001-5570-2622
電子郵件
d508091002
tmu.edu
tw
h-index
3072
引文
31
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
專案
(13)
研究成果
(134)
類似的個人檔案
(6)
指紋
查看啟用 Yuan-Hung Wang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
8%
Arginine
11%
Biochemical Recurrence
6%
Biological Marker
11%
Bladder Cancer
31%
Cancer Staging
9%
Carcinogenesis
14%
Carcinogenicity
11%
Cardiovascular Disease
8%
Cardiovascular Mortality
6%
Carotid Atherosclerosis
17%
Case-Control Study
6%
Chronic Disease
8%
Chronic Kidney Failure
7%
Chronic Obstructive Lung Disease
15%
Cigarette Smoking
36%
Cohort Study
17%
Diabetes Mellitus
6%
Disease
16%
Disease Exacerbation
6%
Dyslipidemia
7%
End Stage Renal Disease
12%
Glutathione
13%
Heme Oxygenase 1
5%
Hemodialysis
19%
Hypoxia
6%
Infection
16%
Intestine Cancer
8%
Long Term Exposure
8%
Lung Cancer
17%
Malignant Neoplasm
30%
Methanearsonic Acid
8%
Mouse Model
6%
Neoplasm
20%
Overall Survival
13%
Palmoplantar Keratoderma
6%
Prospective Study
6%
Prostate Cancer
34%
Prostate Specific Antigen
7%
Protein P53
12%
Recurrent Disease
14%
Secondary Hyperparathyroidism
11%
Skin Cancer
11%
Sulfotransferase 1A1
11%
Survivin
11%
Thyroid Cancer
11%
Transferase
13%
Transitional Cell Carcinoma
100%
Vaccination Policy
11%
Well Water
23%
Medicine and Dentistry
Alzheimer's Disease
6%
Apoplexy
11%
Atrial Fibrillation
11%
Bladder
13%
Bladder Cancer
22%
Cancer
8%
Carcinogenicity
11%
Carotid Atherosclerosis
11%
Chronic Kidney Disease
13%
Chronic Obstructive Pulmonary Disease
12%
Cigarette Smoking
9%
Cohort Analysis
23%
Cohort Effect
7%
COVID-19
18%
Cytotechnology
7%
Diabetes Mellitus
13%
Diagnosis
14%
Diagnostic Accuracy
29%
Diagnostic Performance
13%
Disease
12%
End Stage Renal Disease
17%
Genetic Polymorphism
7%
Hazard Ratio
25%
Hemodialysis
7%
Immunohistochemistry
7%
In Vitro
6%
Intestine Cancer
8%
Lung Cancer
18%
Malignant Neoplasm
18%
Mediator
8%
Meta-Analysis
46%
Metastatic Carcinoma
8%
Neoplasm
19%
Odds Ratio
13%
Overall Survival
10%
Proportional Hazards Model
6%
Prospective Study
7%
Prostate Cancer
29%
Prostate Specific Antigen
7%
Recurrent Disease
13%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Subgroup Analysis
9%
Survivin
11%
Symptom
6%
Systematic Review
17%
Transitional Cell Carcinoma
53%
Treatment Response
14%
Upregulation
12%
Urinary System
9%
Well Water
6%
Biochemistry, Genetics and Molecular Biology
Allele
28%
B Cell
6%
Cancer Cell
14%
Cancer Staging
8%
Carcinogenesis
24%
Cardiovascular Mortality
12%
Case-Control Study
12%
Cell Proliferation
9%
Cell Survival
6%
Cigarette Smoking
16%
Coronavirinae
7%
Disease Free Survival
7%
DNA Methylation
12%
Drive
6%
Dyslipidemia
11%
Embase
11%
Epidermal Growth Factor Receptor
7%
Gene Expression
12%
Gene Polymorphism
35%
Gene Promoter
24%
Genetic Divergence
10%
Genotyping
37%
Heme Oxygenase
17%
Hemodialysis
17%
Inhibitor of Apoptosis
6%
interferon
10%
Interferon
7%
Interleukin 6
11%
Interleukin 8
11%
Interleukin-6
7%
Kinase
6%
Lifespan
6%
Mediator
7%
Medline
14%
Messenger RNA
7%
Methylation
13%
Passive Smoking
11%
Phosphotransferase
6%
Promoter Region
12%
Real-Time Polymerase Chain Reaction
7%
Sample Size
6%
SARS Coronavirus
11%
Signal Transduction
8%
Single-Nucleotide Polymorphism
16%
Smoking
7%
SOX2
11%
Survivin
11%
Tumor Necrosis Factor
10%
Upregulation
9%
XRCC1
7%
